Insight Molecular Diagnostics Inc.

Healthcare · Diagnostics & Research · United States

Last price 3.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 104.06M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test ...